Seres Therapeutics

4 followers

‌

Seres Therapeutics is developing revolutionary microbiome-based therapeutics to treat serious diseases.

Industries

Employees

201-500

Links


Org chart

Eric Shaff
President & CEO
Collapse
Matthew Henn
EVP, Chief Scientific Officer
Terri Young
EVP, Chief Commercial & Strategy Officer
Thomas J. Desrosier
EVP, Chief Legal Officer & Secretary
Ann Kurowski
Sr. Vice President Regulatory Affairs
Georgia Giannopoulos
Senior Vice President, People & Culture
Claire M. Fraser
Director, Institute for Genome Sciences
Nehemie Bernard
Executive Assistant, Cfo, Cmo, CCSO
Stephen McGarry
Director, People Partner
Geoffrey von Maltzahn
Co Founder CTO 2010 2012
Catherine Fagan
Senior Vice President & Chief Information Officer
Chris McChalicher
Svp, Head Of CMC And Quality At Seres Therapeutics
Kevin Kaeding
Senior Director Information Technology
Robbie Stevens
Vice President And Head, Medical Affairs
Dennis M Walling
Vice President, Clinical Development, And Head Of Clinical Research
Jill Colabella
Executive Director, Clinical Operations
Erin Phillips
Senior Quality Assurance Manager

Board & advisors

Andrew Goodman
Scientific Advisor
Curtis Huttenhower
Scientific Advisor
Elhanan Borenstein
Scientific Advisor
Kurt Graves
Board Of Directors; Director
Marcel van den Brink
Scientific Advisor
Mark Wilcox
Scientific Advisor
Paul Biondi
Board Member
Richard Kender
Board Member
Robert Jenq
Scientific Advisory Board
Willard H. Dere
Board Member